MagIA develops an innovative blood immunoanalyzer allowing for easy transfer of any immunoassay onto a portable system, with lab performance.
We deliver our partner’s immunoassays directly to patients through our proprietary Point of Care device.
The growing challenges of personalised medicine and pandemic management drive the need for Point of Care solutions pushing diagnostic companies (10 B$ CAGR) to bring their assays closer to the patient.